# US 2002/0119471 A1 · Method for detection of biological factors in epidermis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0119471 A1
- Document ID: US20020119471A1
- Status: Published application
- Kind: A1
- Application number: 09/976,361
- Filed: 2001-10-11
- Published: 2002-08-29
- Earliest claimed: 1998-08-18
- Inventors: Lawrence A. Rheins; Vera B. Morhenn
- Web page: https://patentgrep.com/patent/US20020119471A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- A61K 49/0006: {Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity}
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed is a method for removing polynucleotide from the skin. This polynucleotide can be used to detect dermatitis and distinguish an irritant reaction from an allergic reaction by characterizing the polynucleotide according to the polypeptide which it encodes. Additionally, provided are methods for non-invasive isolation of samples from the skin as well as kits for use in the methods provided herein.

## Claims

### Claim 1

A method of diagnosing ACD in a subject, comprising quantifying a polynucleotide encoding IL-13 in cells of the subject, wherein an elevated amount of IL-13 is indicative of ACD.

### Claim 2 (depends on 1)

The method of claim 1, wherein the IL-13 is detected by PCR.

### Claim 3 (depends on 1)

The method of claim 1, wherein the IL-13 is detected by hybridization with a polynucleotide probe.

### Claim 4 (depends on 1)

The method of claim 1, wherein the IL-13 is detected by RNase protection assay.

### Claim 5 (depends on 1)

The method of claim 1, wherein the cells are skin cells.

### Claim 6 (depends on 1)

The method of claim 1, wherein the subject is a mammal.

### Claim 7 (depends on 6)

The method of claim 6, wherein the mammal is a human.
